HOME >> BIOLOGY >> NEWS
Acid rain revisited: ESA releases report on the ecological response to acid deposition

Congress will soon give careful consideration to renewal of the Clean Air Act and its amendments. In anticipation of this event, a group of scientific experts met last year to discuss their research of acid deposition, often called acid rain. The results of this meeting have been summarized and are now available in a new report from the Ecological Society of America entitled, "Acid Deposition: The Ecological Response."

The group of experts was composed of 40 of the nation's top ecological researchers. They met in March 1999 with three specific goals in mind: to evaluate the long term trends emerging from research data on ecosystem response to acid deposition; to examine whether changes have occurred in the ecological damage caused by acid deposition, and to compare those changes to observations and projections of the 1990 National Acid Precipitation Assessment Program (NAPAP) Report. During this same year, the Clean Air Act Amendments (CAAA) were passed to reduce the adverse effects of acid deposition through phased reductions of annual emissions of its precursors, sulfur dioxide (SO2) and nitrogen oxides (NOx). The scientists also wanted to ascertain whether ecosystems were experiencing any kind of recovery from previous acid deposition.

The most important conclusions drawn from the workshop regard regional differences in both deposition levels and recovery rates. In the Midwest and Northeast, the scientists agreed, emission reductions of sulfur dioxide correspond to decreases in the fluxes of sulfate in both precipitation and surface waters. But in some regions and ecosystems, these reductions may not have resulted in ecosystem recovery.

Several factors may be limiting this recovery. First, acid deposition can deplete base cations from soils, such as calcium and magnesium, that are essential for plant growth. Besides being essential for plants these elements also neutralize further acid inputs.

Second, nitrogen deposition may also be li
'"/>

Contact: Alison Gillespie
alison@esa.org
202-833-8773 ext. 21
Ecological Society of America
11-May-2000


Page: 1 2 3

Related biology news :

1. 5AM Solutions releases Microarray Enterprise Manage(TM) Software
2. Joslin Diabetes Center releases new low impact exercise video
3. The American Academy of Microbiology releases report
4. Academy Harbor Consortium releases letter on mercury to President Bush
5. The American Academy of Microbiology releases report
6. Journal announces scientific releases
7. ICSU releases GMO synthesis report
8. CAST releases report on environmental impacts of grazing systems on our nations resources
9. Twenty-years of long-term ecological research: National Science Foundation releases review report
10. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
11. Refrigerator disposal releases ozone-depleting chemicals

Post Your Comments:
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: